← Cancer trial database
New trial
Head and neck cancer

Phase 2 GdContrast: Gadolinium agent enhances T1 relaxation for improved margin visualization

Trial ID
NCT07060261 on ClinicalTrials.gov
Cancer type
Tonsillar Cancer
Stage of research
Exploratory
Published in
New in Oncology - July 25, 2025

This prospective study sponsored by Case Comprehensive Cancer Center evaluates whether enhanced pre-operative MRI protocols—including noncontrast, contrast-enhanced, T2 weighted, and T2 SPACE sequences—can predict margin status during transoral robotic surgery in patients with HPV+ tonsillar squamous cell carcinoma. Three neuroradiologists independently grade pharyngeal muscle thickness, aiming to inform surgical planning and optimize patient outcomes.

More in head and neck cancer

See all entries in head and neck cancer →